GLIATECH, INC.

Company Information

Company Name
GLIATECH, INC.
Address
GLIATECH, INC.
23420 COMMERCE PARK RD
CLEVELAND, OH, 44122
Phone
1 216-831-3200
URL
n/a
DUNS
n/a
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,091,889.00
13
SBIR Phase II
$2,093,044.00
3
Chart code to be here

Award List

  1. ARTIFICIAL NERVE GRAFT FOR PERIPHERAL NERVE REPAIR

    Amount: $49,302.00

    THIS PROJECT'S OBJECTIVE IS TO DEVELOP AN ARTIFICIAL NERVE GRAFT FOR REPAIR OF PERIPHERAL NERVE INJURIES. THIS GRAFT WILL CONSIST OF THE PATIENT'S OWN SCHWANN CELLS SEEDED INTO A POLYMER TUBE TO BE IM ...

    SBIR Phase I 1991 Department of Health and Human Services
  2. GLIAL ANTIPROLIFERATIVE FACTOR AS A TUMOROSTATIC AGENT

    Amount: $50,000.00

    MALIGNANT GLIOMAS ARE THE MOST COMMONLY OCCURRING CEREBRAL NEOPLASMS IN HUMANS. THE INCIDENCE OF PRIMARY BRAIN TUMORS IS 16,000 CASES ANNUALLY, WITH MALIGNANT GLIOMAS (GLIOBLASTOMA MULTIFORMS) COMPRIS ...

    SBIR Phase I 1992 Department of Health and Human Services
  3. INHIBITORS OF A GLIAL ANTIPROIFERATIVE FACTOR

    Amount: $50,000.00

    EACH YEAR 300,000 PEOPLE IN THE UNITED STATES SUFFER DAMAGE TO PERIPHERAL NERVES. OF THE 50,000 OPERATIONS PERFORMED, 50% OR LESS ARE SUCCESSFUL. GLIATECH, INC. IS DEVELOPING AN ARTIFICIAL NERVE GRAFT ...

    SBIR Phase I 1992 Department of Health and Human Services
  4. Inhibition of B-Amyloid-Induced Complement Activation

    Amount: $80,249.00

    The hallmark of AD is the formation of cerebral senile plaques, with amyloid beta protein (Abeta)as its principle component. There is ample evidence suggesting that complement activation within andaro ...

    SBIR Phase I 1994 Department of Health and Human Services
  5. Inhibition of Tendon Adhesions By Adcon-T

    Amount: $75,000.00

    Scars form after tendon injury. It binds the tendon and prevents it from gliding freely, resultingin diminished movement in a high percentage of patients. Prophylactic application of an agent thatinhi ...

    SBIR Phase I 1994 Department of Health and Human Services
  6. Development of Novel Chiral Cyclic Histamine H3 Agonists

    Amount: $621,379.00

    The long-term objectives are to synthesize novel cyclic and heterocyclic histamine H3 receptor agonprodrugs thereof that have improved GI absorption and CNS penetration. These agents are being develot ...

    SBIR Phase II 1998 Department of Health and Human Services
  7. Development of Novel Chiral Cyclic Histamine H3 Agonists

    Amount: $100,000.00

    The long-term objectives are to synthesize novel cyclic and heterocyclic histamine H3 receptor agonprodrugs thereof that have improved GI absorption and CNS penetration. These agents are being develot ...

    SBIR Phase I 1995 Department of Health and Human Services
  8. Evaluation of a Novel H3 Antagonist, GT 2016, for Add

    Amount: $721,665.00

    The long-term objectives are to develop novel histamine H3 receptor antagonists to increase wakefuland enhance cognitive abilities. The specific aims of this grant are (1) to test a novel non- thiourf ...

    SBIR Phase II 1997 Department of Health and Human Services
  9. N/A

    Amount: $750,000.00

    N/A

    SBIR Phase II 1999 Department of Health and Human Services
  10. NOVEL GLYCINE TRANSPORTER INHIBITORS FOR SCHIZOPHRENIA

    Amount: $93,862.00

    The glutamate/glycine NMDA receptor has been implicated in a variety of central nervous system disorders and pathological conditions. In particular, NMDA receptor hypofunction may contribute significa ...

    SBIR Phase I 2002 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government